Suxiang Chen
Murdoch, WA 6150, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
WDR91, an endosomal maturation protein, promotes antisense oligonucleotide activity.
Journal: Molecular therapy. Nucleic acids
Published: May 08, 2026
Survivin-Targeting Antisense Oligonucleotides in Cancer Therapy.
Journal: Molecules (Basel, Switzerland)
Published: April 14, 2026
An LNA gapmer antisense oligonucleotide inhibitor of human NNMT.
Journal: Molecular therapy. Nucleic acids
Published: December 01, 2025
Systematic evaluation of 2'-O-methyl RNA antisense oligonucleotides with limited phosphorothioate linkages for efficient splice switching.
Journal: Chemical communications (Cambridge, England)
Published: October 06, 2025
A single stereogenic center matters: Development of stereodefined anti-tau PMO-gapmers.
Journal: Molecular therapy. Nucleic acids
Published: September 10, 2025
Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: August 05, 2025
Targeting NAT10 with Remodelin reshapes the pro-fibrotic microenvironment in renal fibrogenesis via inhibiting exosome oversecretion from tubular cells.
Journal: Acta pharmaceutica Sinica. B
Published: February 09, 2025
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: January 03, 2024
Metallic nanostructure-based aptasensors for robust detection of proteins.
Journal: Nanoscale advances
Published: September 11, 2023
Nanoparticles-assisted aptamer biosensing for the detection of environmental pathogens.
Journal: Environmental research
Published: July 27, 2023
Last Updated: 09/26/2026